Citryll, a Dutch pharmaceutical company, held the first closing of a targeted 15 million euros funding round. The backers were ModiQuest B.V., BOM Brabant Ventures, BrightGene and Curie Capital.
Source: Press Release
Citryll, a Dutch pharmaceutical company, held the first closing of a targeted 15 million euros funding round. The backers were ModiQuest B.V., BOM Brabant Ventures, BrightGene and Curie Capital.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: